Status:
UNKNOWN
Hyposalivation Response To Transcutaneous Electrical Nerve Stimulation In Diabetic Type 2 Patients
Lead Sponsor:
Cairo University
Conditions:
Diabetes type2
Hyposalivation
Eligibility:
All Genders
50-90 years
Phase:
NA
Brief Summary
This study evaluates response of abnormal low salivary flow rate to transcutaneous electrical nerve stimulation (TENS) in diabetic type 2 patients. Response of saliva monitored for all participants re...
Detailed Description
Diabetes mellitus is the most significant disorder associated with varied oral manifestation ranging from xerostomia (subjective sensation od dry mouth) to serious bacterial and fungal infections due ...
Eligibility Criteria
Inclusion
- non-smoker diabetic patients type II
- Patients with unstimulated resting saliva ≤ 0.16 ml/min considered to be abnormally low flow rate and included in the study (Navazesh et al., 1992)
Exclusion
- Cancer patients (patients on chemotherapy/immunotherapy and history of head and neck radiotherapy).
- Cardiac patients (cardiac pacemakers and defibrillators).
- Patients wearing hearing aids.
- Chronic inflammatory autoimmune diseases
- Acute oral inflammatory disorders
- Patients with neurological disorders.
- Habits (mouth breathing, smoking, alcohol and drug abuse).
- Salivary gland diseases and disorders.
- Psychogenic diseases.
- Endocrine diseases.
- Patients undergoing pharmacological management for xerostomia.
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03435328
Start Date
January 1 2017
End Date
May 1 2018
Last Update
February 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University Hospitals
Giza, Cairo Governorate, Egypt, 11511